These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 232771)

  • 1. [Clinical pharacology of the new antihypertensive drugs: renin-angiotensin system antagonists, recent vasodilators and dopaminergic agonists].
    Andréjak M; Hardin JM; Makdassi R; Bataille P; Gheerbrant JD; Fournier A
    Rev Prat; 1979 Dec; 29(57):4385-93. PubMed ID: 232771
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilating antihypertensive drug-induced aldosterone release--a study of endogenous angiotensin-mediated aldosterone release in the rat.
    Campbell WB; Pettinger WA; Keeton K; Brooks SN
    J Pharmacol Exp Ther; 1975 Apr; 193(1):166-75. PubMed ID: 1167223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of angiotensin II and antagonists of the renin-angiotensin system on the cerebral circulation].
    Adzhienko LM
    Eksp Klin Farmakol; 2000; 63(4):74-9. PubMed ID: 11022315
    [No Abstract]   [Full Text] [Related]  

  • 4. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New antihypertensive agents].
    Hayduk K
    Med Klin; 1979 Jul; 74(30):1107-15. PubMed ID: 39232
    [No Abstract]   [Full Text] [Related]  

  • 6. Various approaches to blockade of the renin-angiotensin system: persistent renin response.
    Brunner HR; Nussberger J; Waeber B
    J Hypertens Suppl; 1990 Dec; 8(7):S149-53. PubMed ID: 2095383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern concepts in the drug treatment of arterial hypertension.
    van Zwieten PA
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):412-9. PubMed ID: 6108920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin antagonists.
    Brunner HR; Nussberger J; Waeber B
    Adv Nephrol Necker Hosp; 1993; 22():305-27. PubMed ID: 8427061
    [No Abstract]   [Full Text] [Related]  

  • 10. [The renin-angiotensin system and drugs].
    Saruta T
    Nihon Rinsho; 1982; 40(9):2059-66. PubMed ID: 6130174
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
    Kuska J; Germakowska-Kowalik T; Pluta S
    Postepy Hig Med Dosw; 1982; 35(4):395-411. PubMed ID: 6183653
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antihypertensive drugs].
    Peters G; Peters-Haefeli L
    Rev Med Suisse Romande; 1974 Aug; 94(8):589-614. PubMed ID: 4373810
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical pharmacology of antihypertensive drugs.
    Lowenthal DT; Saris SD; Haratz A; Packer J; Porter RS; Conry K
    J Hypertens Suppl; 1984 Dec; 2(2):S13-24. PubMed ID: 6152830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The advantages of angiotensin II antagonism.
    Burnier M; Waeber B; Brunner HR
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin inhibitors.
    Haber E
    N Engl J Med; 1978 May; 298(18):1023-5. PubMed ID: 205787
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitors of the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    Arzneimittelforschung; 1993 Feb; 43(2A):274-8. PubMed ID: 8498978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin II AT1 receptor antagonists: clinical development and future perspectives].
    Burnier M; Brunner HR
    Therapie; 1998; 53(3):279-84. PubMed ID: 9773127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A; Redón J
    Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin-II receptor antagonists: a new class of antihypertensive agents.
    Weir MR
    Am Fam Physician; 1996 Feb; 53(2):589-94. PubMed ID: 8629540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.